Postoperative Analgesic Effects of Using Dexmedetomidine for Ultrasound Guided Thoracic Paravertebral Block
Phase 4
Completed
- Conditions
- Pain
- Interventions
- Registration Number
- NCT02544893
- Lead Sponsor
- TC Erciyes University
- Brief Summary
we aimed postoperative analgesic effects of using bupivacaine alone or added dexmedetomidine for ultrasound guided thoracic paravertebral block in thoracotomy
- Detailed Description
paravertebral block is commonly used in the treatment for acute and chronic pain.The duration of paravertebral block could theoretically be prolonged with neurolytic agents. Dexmedetomidine ,an alfa-2 adrenoreceptor agonist, is being used and adjuvant capable of prolonging duration of sensory and motor block on nerve blocks.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 93
Inclusion Criteria
- ASA 1-2
- 18-65 aged
- patient undergoing thoracotomy
Exclusion Criteria
- chronic opioid consumption
- bupivacaine and dexmedetomidine allergies
- coagulopathy
- infection at the needle insertion side
- chronic liver and kidney disease
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Arm && Interventions
Group Intervention Description serum phsyologic serum physiologic 0,9% 21 ml serum physiologic bupivacaine bupivacaine 0,5% 20 ml bupivacaine added 0.9% 1 ml serum physiologic on paravertebral block dexmedetomidine dexmedetomidin 100 mcg dexmedetomidine added to 0,5% 20 ml bupivacaine on paravertebral block
- Primary Outcome Measures
Name Time Method opioid consumption postoperative 24 hours patient controlled analgesia
- Secondary Outcome Measures
Name Time Method visual analog scale postoperative 1 day visual analog scale
Trial Locations
- Locations (1)
Erciyes University Medicine Faculty
🇹🇷Kayseri, Turkey